Kestra Medical Technologies, Inc. Secures $196M Funding Round to Revolutionize Cardiac Monitoring with Wearable Solutions

Kestra Medical Technologies, Inc. is thrilled to announce the successful closing of a $196 million funding round, a pivotal step in advancing our mission to safeguard patients-at-risk and empower the caregivers who support them. Based in Kirkland, Washington, and backed by Bain Capital, we focus on revolutionizing cardiac monitoring through innovative wearable technologies and applications. In a world where cardiovascular disease remains the leading cause of death, our commitment to redefining treatment protocols is more critical than ever. This significant financial boost will enable us to accelerate the development of our cutting-edge cardiac monitoring products, enhancing both patient comfort and clinical oversight. Our goal is to streamline the recovery process, making it easier for patients to navigate challenging medical events while providing their healthcare teams with the valuable insights they need to deliver tailored care. By leveraging this funding, we intend to drive our research and development initiatives forward, ultimately bringing new, life-saving solutions to the market. At Kestra, we stand firm in our belief that through collaboration and innovation, we can transform the standard of care for individuals affected by cardiovascular disease. As we embark on this exciting journey, we invite you to join us in our mission to protect and empower patients worldwide. For more information on our initiatives and vision, please visit us at www.kestramedical.com.